Patient blood management is a patient-focused, evidence-based and systematic approach to optimize care of patients, who might need a blood transfusion, by optimizing patients’ blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions. The patient blood management market is segmented by product into instruments, accessories, reagents and kits, software. The patient blood management kits are used to manage the patient’s blood. It is also segmented by component into plasma, whole blood, and red blood cells that are used for applications such as hospitals, clinics, and others. The patient blood management market research report is one of a series of new reports from The Business Research Company that provides patient blood management market statistics, including patient blood management industry global market size, regional shares, competitors with a patient blood management market share, detailed patient blood management market segments, market trends and opportunities, and any further data you may need to thrive in the patient blood management industry. This patient blood management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient blood management market grew from $12.82 billion in 2022 to $13.83 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient blood management market is expected to grow from $17.42 billion in 2027 at a CAGR of 6.0%. The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents. According to the Centers for Disease Control and Prevention, in 2021, the caesarean birth rate was 32.1% of all the births. Increased number of accidents, trauma cases, and surgical procedures resulted in increased demand for blood, and its products are driving the global patient blood management market. The high cost associated with automated systems is expected to limit the growth of the global patient blood management market. Costs associated with an increasing regulatory requirement, infection testing, and hospital administration, which include initial project costs, personnel salaries, costs of equipment, outside resources, and ongoing project costs make automation expensive. According to the Researchgate, in 2022, the expected cost of transfusion of one unit of red cells is US$ 600–$1200. The high economic cost of automation is therefore expected to hamper the global patient blood management market. HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss. Clinicians can economically collect sterile, anticoagulated blood without any need for specialized resources. By this, the upfront shed blood collection cost decreases, allogenic transfusions can be avoided with improved outcomes such as decreased patient mortality, low incidence of infections, and reduced risk of multi-organ failure. Major players in the patient blood management market are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, Kaneka Corporation, and Bio-Rad Laboratories Inc. North America was the largest region in the patient blood management market in 2022. Western Europe was the second largest region in the global patient blood management market report. The regions covered in the global patient blood management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient blood management market is segmented - 1) By Product: Instruments, Accessories, Reagents And Kits, Softwares 2) By Component: Plasma, Whole Blood, Red Blood Cells 3) By Application: Hospital, Clinic, Other Applications

Vital parameter monitoring devices and equipment are used to monitor critical parameters such as blood pressure, heart rate, and other physiological parameters. The main product types of vital parameter monitoring devices and equipment are blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Blood pressure monitoring devices are electronic devices that are used to monitor blood pressure. The blood pressure monitoring devices are aneroid BP monitors, digital BP monitors, ambulatory BP monitors, and blood pressure instrument accessories. The pulse oximeters are table-top/bedside pulse oximeters, fingertip pulse oximeters, hand-held pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters. The temperature monitoring devices are digital thermometers, infrared thermometers, and temperature strips. The various end-users are hospitals, clinics, ambulatory surgery centres, and home care settings. The vital parameter monitoring devices and equipment market research report is one of a series of new reports from The Business Research Company that provides vital parameter monitoring devices and equipment market statistics, including vital parameter monitoring devices and equipment industry global market size, regional shares, competitors with a vital parameter monitoring devices and equipment market share, detailed vital parameter monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the vital parameter monitoring devices and equipment industry. This vital parameter monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global vital parameter monitoring devices and equipment market size will grow from $6.62 billion in 2022 to $7.13 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vital parameter monitoring devices and equipment market size is expected to grow to $9.14 billion in 2027 at a CAGR of 6.4%. An increase in the geriatric population globally is driving the vital parameter monitoring devices and equipment market. Old people are more prone to medical conditions and diseases and require monitoring of vital health parameters. According to the World Health Organization, in 2020, there were about 1 billion people aged 65 years or above and the number is expected to reach 1.4 billion by 2030 and 2.1 billion by 2050.. The increasing number of old age patients seeking treatments and surgeries is contributing to market growth. The security concerns related to wireless vital parameter monitoring devices are acting as a restraint on the vital parameter monitoring devices and equipment market. Medical devices with features like wireless connectivity, remote monitoring, and near-field communication allow health professionals to monitor vital parameters like electrocardiogram (ECG), blood pressure (BP), and temperature from anywhere with convenience. These devices are connected to a broad network via IoT, making them potential entry points to larger hospital networks. This connectivity could be used by hackers to mount a ransomware attack against a large hospital and can hold the vital systems of the hospital hostage, or breach sensitive medical records. The medical data obtained in these types of attacks can be used for malicious activities like tax fraud or identity theft, and can even be used to track active drug prescriptions. According to Linchpinseo data 2022, Nearly 4 million connected devices monitor every part of the human body. Vital parameter monitoring devices and equipment companies are increasingly investing in the research and development of wearable health devices (WHDs). WHDs are smart electronic devices that can be worn by a consumer and are capable of tracking information related to health and fitness. These devices facilitate better monitoring of health and can help in early diagnosis and guidance from doctors. For instance, the ViSi Mobile developed by Sotera Wireless is a wearable device that can provide many vital parameters such as heart rate, respiration rate, oxygen saturation, pulse rate, etc. VitalTag is another wearable device developed as part of the Department of Homeland Security Science and Technology Directorate program to detect and monitor heart rate, blood oxygen levels, body temperature, and blood pressure. Current Health recently got FDA approval for an artificial intelligence-powered wearable device that monitors patient vital signs at the hospital and home. Vital parameter monitoring devices and equipment manufacturers are governed by the various quality and safety regulations. For instance, in the USA, the Food and Drug Administration's 510 (k) regulation for safety and effectiveness of vital parameter monitoring devices and equipment states that the device should be tested non-clinically for electrical safety, electromagnetic compatibility. Vital parameter monitoring devices and equipment are classified as class II under title 21, parts 800 to 898 by FDA. Class II devices are medical devices having a moderate risk. Major players in the vital parameter monitoring devices and equipment market are Welch Allyn (Hill-Rom Holdings), SunTech Medical (Halma plc), Masimo Corporation, General Electric Company, Medtronic PLC., Nihon Kohden Corporation, Koninklijke Philips N.V, A&D Company, Contec Medical Systems Co., and Nonin Medical. Asia-Pacific was the largest region in the global vital parameter monitoring devices and equipment market in 2022. North America was the second-largest region in the v tal parameter monitoring devices and equipment market. The regions covered in the global vital parameter monitoring devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vital parameter monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The vital parameter monitoring devices and equipment market consist of sales of instruments such as blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global vital parameter monitoring devices and equipment market is segmented - 1) By Product Type: Blood Pressure Monitoring Devices, Pulse Oximeters, Temperature Monitoring Devices 2) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings 3) By Blood Pressure Monitoring Devices: Aneroid BP Monitors, Digital BP Monitors, Ambulatory BP Monitors, Blood Pressure Instrument Accessories 4) By Pulse Oximeters: Table-top/Bedside Pulse Oximeters, Fingertip Pulse Oximeters, Hand-held Pulse Oximeters, Wrist-worn Pulse Oximeters, Pediatric Pulse Oximeters 5) By Temperature Monitoring Devices: Digital Thermometers, Infrared Thermometers, Temperature Strips

Remote patient monitoring devices and equipment allow a patient to use a mobile medical device for a routine test and send the test data to a healthcare expert in real-time. The main type of device of remote patient monitoring devices and equipment are heart monitors, breath monitors, hematology monitors, and multi-parameter monitors. A heart monitor is a device that records the electrical activity of the heart. This device is the size of a pager. The various applications involved are cancer treatment, cardiovascular diseases, diabetes treatment, sleep disorders, weight monitoring, fitness monitoring, and other applications. The various end-users involved are home care settings, clinics, and hospitals. The remote patient monitoring devices and equipment market research report is one of a series of new reports from The Business Research Company that provides remote patient monitoring devices and equipment market statistics, including remote patient monitoring devices and equipment industry global market size, regional shares, competitors with a remote patient monitoring devices and equipment market share, detailed remote patient monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the remote patient monitoring devices and equipment industry. This remote patient monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global remote patient monitoring devices and equipment market size will grow from $1.18 billion in 2022 to $1.34 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The remote patient monitoring devices and equipment market size is expected to grow to $2.14 billion in 2027 at a CAGR of 12.5%. The upcoming shortage of skilled healthcare professionals (doctors and nurses), drives the remote patient monitoring (RPM) devices and equipment market. As the number of patients with chronic diseases is increasing, it is getting difficult to monitor the patients due to operational time and cost-related issues. The rising number of patients with chronic diseases, increasing the need for monitoring, and projected shortfall in the number of nurses shortly increase the growth of remote patient monitoring devices and equipment. According to a report by Mercer, the US requires 2.3 million new health care workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. According to the Bureau of Labor Statistics, there is an additional need for 203,700 new registered nurses every year by 2026. However, only 438,100 nurses are expected to be added to 2026, which is way less than the demand. World Health Organization (WHO) projected that by 2030, low- and middle-income countries will have a deficit of 14.5 million healthcare professionals. The remote patient monitoring devices market is limited, as healthcare professionals are averse to adopting new technologies. Technologically advanced remote patient monitoring devices and equipment are adopted to reduce patients’ expenditure on hospitalization in terms of follow-up care. The rise of such adoption results in a reduction of hospital revenues. Therefore, hospitals and healthcare professionals resisted the adoption of remote patient monitoring systems and are limiting the market. For instance, a case study in the UK states, organizational barriers at various levels, technical, social, ethical, financial, and legal factors are restraining to investment, implementation action, and use of advanced patient monitoring systems. Remote patient monitoring device manufacturers are increasingly integrating IoT and wireless technology with remote patient monitoring devices to efficiently diagnose and treat medical conditions. Wireless sensor technology such as biosensor monitoring devices is multi-sensor systems implanted or embedded into the skin, consisting of a sensor that transmits data for real-time monitoring of a patient’s medical condition. IoT technology enables healthcare service providers to remotely monitor patients’ health parameters. These devices are miniaturized multi-sensing devices, aiding healthcare professionals to monitor blood pressure, blood glucose levels, and physiological parameters, and recommend the appropriate treatment. Major companies offering IoT and wireless sensor technology integrated patient monitoring devices include Xsensio, InSilixa, 1Drop Diagnostics, Kenzen. The remote patient monitoring device and equipment manufacturers must comply with the rules and regulations of the Health Insurance Portability and Accountability Act (HIPAA). These HIPAA regulations secure definitions of the network, take physical security, and process security measures regarding the Protected Health Information (PHI). Title II of HIPPA directs the Health and Human Services (HHS) of the U.S Department to manifest national standards for the exchange of electronic healthcare data and information. Health and Human Services (HHS). The Office for Civil Rights (OCR) issued guidance clarifying that cloud service providers and other business associates of healthcare organizations are covered by the HIPAA privacy, security, and breach notification rules for safe and secure electronic data interchange. In October 2021, Carbon Health, a US-based telemedicine company, acquired Alertive Healthcare for an undisclosed amount. The acquisition would accelerate Carbon Health’s omnichannel care delivery strategy and extend its portfolio in home-based care and remote patient care. Alertive Healthcare is a UK-based remote patient monitoring company. Major players in the remote patient monitoring devices and equipment market are Philips Healthcare, Honeywell, GE Healthcare, Medtronic, Boston Scientific, Johnson & Johnson, Biotronik, Robert Bosch, COVIDien PLC., and St. Jude Medical. Asia-Pacific was the largest region in the global remote patient monitoring devices and equipment market in 2022. North America was the second-largest region in the remote patient monitoring devices and equipment market. The regions covered in the global remote patient monitoring devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the remote patient monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The remote patient monitoring devices and equipment market consists of sales of instruments such as heart monitors, breath monitors, and multi-parameter monitors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global remote patient monitoring devices and equipment market is segmented - 1) By Type Of Device: Heart Monitors, Breath Monitors, Haematology Monitors, Multi - Parameter Monitors 2) By End User: Home Care Settings, Clinics, Hospitals 3) By Application: Cancer Treatment, Cardiovascular Diseases, Diabetes Treatment, Sleep Disorder, Weight Monitoring And Fitness Monitoring, Other Applications

Patient monitoring devices are machines that are used to constantly monitor patients through various vital signs and warning systems to detect and record changes in patient health conditions. The main types of patient monitoring devices market are fetal and neonatal monitoring devices, weight monitoring and body temperature monitoring devices and equipment, vital parameter monitoring devices and equipment, and remote patient monitoring devices and equipment. Fetal and neonatal monitoring devices measure the heart rate and rhythm of the baby (fetus). This lets the healthcare providers see how the baby is doing. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides patient monitoring devices market statistics, including patient monitoring devices industry global market size, regional shares, competitors with a patient monitoring devices market share, detailed patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the patient monitoring devices industry. This patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient monitoring devices market grew from $23.46 billion in 2022 to $25.53 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient monitoring devices market is expected to grow to $34.5 billion in 2027 at a CAGR of 7.8%. The demand for monitoring devices is likely to increase due to the shortage of professionals in the healthcare services industry. According to a report by Mercer, the US requires 2.3 million new healthcare workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. This shortage is likely to drive the demand for monitoring systems as these devices allow medical professionals to track multiple patients remotely. This is expected to drive the market for patient monitoring devices in the forecast period. Awareness of diseases is low in many countries across the globe, and this affected the demand for patient monitoring devices in the historic period. For instance, a study conducted by the Indian Council of Medical Research (ICMR) on 213 million people found that only 43.2% are aware of the chronic disease diabetes. This lack of disease awareness limited the diagnosis and treatment pool, thereby restricting market growth for patient monitoring devices. Patient monitoring device manufacturers are offering customized MPMs to cater to the growing patient pool. MPMs monitor different health parameters corresponding to patients’ health conditions. For instance, Infinium Medical’s Omni series monitors are preconfigured with ECG, oxygen saturation, non-invasive blood pressure, and temperature trackers. More advanced health measures such as invasive blood pressure, cardiac output, and anaesthetic agent measurement can be added to this device when needed. Custom MPM is predominantly beneficial for tracking the health status of critically ill patients. Major companies in the patient monitoring devices market include General Electric Company, Koninklijke Philips N.V., Draegerwerk AG, Cardinal Health, Inc., Masimo, Stryker Corporation, Medtronic Inc., Edwards Lifesciences, Flex Ltd., and Nihon Kohden Corporation. Asia-Pacific was the largest region in the global patient monitoring devices market in 2022. North America was the second-largest region in the global patient monitoring devices market. The regions covered in the patient monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient monitoring devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The patient monitoring devices market consist of sales of instruments such as blood pressure cuffs, glucometers, pulse oximeter, ECG + stethoscope, wearables (activity trackers and continuous monitoring), and thermometers for patient monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient monitoring devices market is segmented - 1) By Type: Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Fetal Monitoring Devices, Neonatal Monitoring Devices, Temperature Monitoring Devices, Weight Monitoring Devices, Cardiac Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Multiparameter Monitoring Devices, Cardiac Monitors, Respiratory Monitors, Hematological Monitors, Vital Parameter Monitors And Other End Users

Patient portal is an online website service opted for by hospitals that gives patients easy access to health information such as recent doctor visits, prescription refills, medications, discharge summaries, and others. It is used to provide 24/7 access about the healthcare data to the patients. The main types of patient portals are standalone patient portals and integrated patient portals. Integrated patient portals refer to a direct connection to the patient database of a medical facility or organisation and are capable of providing a wide variety of functions and services. The deployment models are on-premise and cloud-based. The various end-users involved are providers, payers, pharmacies, and other end-users. The patient portal market research report is one of a series of new reports from The Business Research Company that provides patient portal market statistics, including patient portal industry global market size, regional shares, competitors with a patient portal market share, detailed patient portal market segments, market trends and opportunities, and any further data you may need to thrive in the patient portal industry. This patient portal market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient portal market size grew from $3.63 billion in 2022 to $4.34 billion in 2023 at a compound annual growth rate (CAGR) of 19.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient portal market size is expected to grow to $8.78 billion in 2027 at a CAGR of 19.3%. The increase in demand for electronic health records is expected to propel the growth of the patient portal market going forward. The electronic health record refers to a systematic collection of real-time data of patients in digital format by physicians or hospitals, whose information is instantly and securely available by authorised users. Electronic health record (EHR) patient portals provide a means by which patients will access their health information, including diagnostic test results. For instance, in 2021, according to National Coordinator for Health Information Technology (ONC), an entity within the U.S Department of Health and Human Services (HHS) data, approximately 86% of non-Federal general acute care hospitals' physicians have adopted electronic health records to treat patients. Therefore, the increasing demand for electronic health records is driving the growth of the patient portal market. Product innovation is a key trend gaining popularity in the patient portal market. Major companies operating in the patient portal sector are focused on developing new product innovation solutions to strengthen their position. For instance, in 2021, McKesson, a US-based healthcare company that provides patient portals, launched ScriptPASTM, a pharmacy management solution for oncology practises powered by Biologics by McKesson specialty pharmacy. ScriptPASTM is a fee-for-service offering designed to help Medically Integrated Dispensing (MID)-equipped practises provide quicker access to care by reducing barriers that delay treatment. This has been accomplished by providing support with benefits investigation, prior authorization, and financial assistance. In November 2021, Virgin Plus, a Canada-based software and services company operating in healthcare, such as patient portals, acquired Welltok, Inc., for an undisclosed amount. Through this acquisition, Virgin Plus aims to enhance its patient portal platform by integrating Welltok’s personalization and analytics capabilities into home-based health care. Welltok, Inc., is a US-based company operating in designing and developing patient platforms. Major players in the patient portal market are Allscripts Healthcare Solutions Inc., McKesson Corporation, athenahealth Inc., Cerner Corporation, eClinicalWorks, CureMD Healthcare, NextGen Healthcare Information Systems LLC, Greenway Health LLC, Medfusion Inc., Epic Systems Corporation Inc., General Electric (GE) Co. (GE Healthcare), InteliChart, QSI Management LLC, Optum Inc., and ZH Healthcare Inc. North America was the largest region in the patient portal market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient portal market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the patient portal market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The patient portal market consists of sales of open patient portals, closed patient portals, and hybrid portals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient portal market is segmented - 1) By Type: Standalone Patient Portals, Integrated Patient Portals 2) By Deployment Mode: On-Premise, Cloud-Based 3) By End-Users: Providers, Payers, Pharmacies, Other End-Users (Employer Groups and Government Bodies)

The patient safety and risk management software is a computer program used in risk management by analyzing and reporting medical issues that arise in healthcare institutions. This program is also used for reduction and prevention of such kind of errors. Patient safety concentrates on minimizing harm to patients whereas risk management prioritizes patient harm as well as other forms of hazards. The main types of patient safety and risk management software are risk management and safety solutions, claims management solutions, and governance, risk and compliance solutions. The risk management and safety solutions are applied for risk management by analyzing and reporting medical issues that arise in healthcare institutions. Risk assessment and reduction are both included in safety risk management. The various types of deployment modes in patient safety and risk management software include private cloud and public cloud. They are adopted by hospitals, ambulatory care centers, long-term care centers, pharmacies, and other end users. The patient safety and risk management software market research report is one of a series of new reports from The Business Research Company that provides Patient safety and risk management software market statistics, including Patient safety and risk management software industry global market size, regional shares, competitors with a Patient safety and risk management software market share, detailed Patient safety and risk management software market segments, market trends and opportunities, and any further data you may need to thrive in the Patient safety and risk management software industry. This Patient safety and risk management software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient safety and risk management software market size grew from $2.02 billion in 2022 to $2.23 billion in 2023 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient safety and risk management software market size is expected to grow to $3.37 billion in 2027 at a CAGR of 10.9%. The increasing adoption of IT in healthcare sector is expected to propel the growth of the patient safety and risk management software market going forward. The healthcare industry has benefited greatly from advances in information technology (IT). Electronic medical records are one example of a huge improvement that IT has given to hospitals (EMR). With the use of this technology, medical data can be compiled into a single database. Use of digital tools and teleconsultation is another recent advance in information technology (IT) in Healthcare. For Instance, in 2020, during the pandemic lockdown in India, 85% of practitioners used digital tools and teleconsultation. On the other hand, first-time users accounted for 80% of all teleconsultation services. When compared to 2019, telehealth visits grew by 50% in 2020.Therefore, the adoption of IT in healthcare sector is expected to propel the growth of patient safety and risk management software market going forward. Adopting different innovative technologies have emerged as a key trend in patient safety and risk management software market. Innovative technology is a term used to describe a technological or scientific process or product that is characterized in terms of production, research, and development. The companies operating in the patient safety and risk management software market are focusing on developing innovative products with latest technologies to increase customer reach and expand their business offerings. For instance, In May 2022, Mindray, one of the leading global providers of medical devices and solutions has launched M-Connect IT Solution, helping optimize clinical workflow and ensure patient safety in hospitals. In June 2021, RLDatix, a UK-based provider of healthcare governance, risk, and compliance (GRC) solutions acquired Allocate for an undisclosed amount. With this acquisition, RLDatix will combine its industry-leading patient safety, compliance, risk and provider management capabilities. Allocate, a UK-based provider of human capital management solutions that help healthcare organizations deliver effective care and safe. Major players in the patient safety and risk management software market are Conduent, Becton, Dickinson and Company, Health Catalyst, Inc., RLDatix, Riskconnect, Inc., Clarity Group, Symplr, RiskQual Technologies, Smartgate Solutions Ltd., Prista Corporation, Ideagen plc, IQVIA Holdings Inc., NAVEX Global Inc., and Wolters Kluwer N.V. North America was the largest region in the patient safety and risk management software market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient safety and risk management software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the patient safety and risk management software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The patient safety and risk management software market consist of revenues earned by entities by providing patient safety and risk management software used to analyze and report medical issues. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient safety and risk management software market is segmented - 1) By Type: Risk Management And Safety Solutions, Claims Management Solutions, Governance, Risk And Compliance Solutions 2) By Deployment Mode: Private Cloud, Public Cloud 3) By End-User: Hospitals, Ambulatory Care Centers, Long-Term Care Centers, Pharmacies, Other End Users

Patient registry software refers to a structured system for gathering non-clinical or clinical patient data to evaluate certain outcomes using observational study methodologies. The main types of products in patient registry software are integrated software and standalone software. The various types of databases are disease registries, health service registries, and product registries. The disease registry is used in the state of a particular disease or condition as the inclusion criterion. A disease registry refers to a unique database that includes data on people who have been diagnosed with a certain disease type. The different deployment models include on-premise and cloud-based that involve several functionalities such as population health management, patient care management, medical research and clinical studies, health information exchange, point-of-care, and product outcome evaluation. It is employed by government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, and research centers. The patient registry software market research report is one of a series of new reports from The Business Research Company that provides patient registry software market statistics, including patient registry software industry global market size, regional shares, competitors with patient registry software market share, detailed patient registry software market segments, market trends and opportunities, and any further data you may need to thrive in the patient registry software industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global patient registry software market size grew from $1.82 billion in 2022 to $2.08 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient registry software market size is expected to grow to $3.54 billion in 2027 at a CAGR of 14.2%. The rising adoption of electronic medical records (EMRs) is contributing to the growth of the patient registry software market going forward. An electronic medical record is a digital counterpart of a patient's paper chart. An EMR can help with billing, inter-practice referrals, appointment scheduling, and medication refills. The patient registry software functionality is included as an add-on in EMR and EHR products, thereby promoting the patient registry software market. For instance, in 2021, according to a UK-based intergovernmental organization, the Organization for Economic Co-operation and Development (OECD), 93% of primary care practices across 24 OECD countries use EMRs. Therefore, the rising adoption of electronic medical records will drive the growth of the patient registry software market. Product innovations are the key trends gaining popularity in the patient registry software market. Major companies operating in the patient registry software sector are focused on developing new product innovations to strengthen their position in the market. For instance, In January 2022, Seqster PDM, Inc., a US-based healthcare company that builds comprehensive patient records partnered with the National Pancreas Foundation to develop a registry software that gathers data using remote monitoring devices. The partnership will leverage Seqster's technology, which combines patient information from wearable/remote monitoring devices, genomic DNA tests, and EHR in real-time. The company's platform gathers patient data from various sources, enabling more thorough, coordinated care. The National Pancreatic Cancer Foundation (NPCF) is a nonprofit group providing independent support for those affected by pancreatic cancer. In June 2021, MRO Corp., a US-based software company, acquired FIGmd for an undisclosed amount. With this acquisition, MRO aimed to expand its ability to efficiently acquire, ingest, manage, and exchange clinical information across multiple sources and formats to deliver actionable insights. FIGmd is an India-based software company that assists healthcare companies in measuring, assessing, and enhancing clinical quality data. Major players in the patient registry software market are IFA Systems AG, Imagetrend Inc., IQVIA Holdings Inc., Lumedx Healthcare Technologies Private Limited, M2s Industries Private Limited, Mckesson Corporation, Opentext Corporation, Optum Health & Technology Private Limited, Syneos Health Inc., Phytel Inc., Dacima Software Inc., Evado Clinical Software, Telligen Inc., Global Vision Technology Co. Ltd., Armus Digital Pvt. Ltd., AltaVoice, Gz Technology Pvt. Ltd., Healthmonix, and Premier Inc. North America was the largest region in the patient registry software market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient registry software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The patient registry software market consists of sales of software and services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient registry software market is segmented - 1) By Product: Standalone Software, Integrated Software 2) By Type of Database: Disease Registries, Health Service Registeries, Product Registries 3) By Deployment Model: On-Premise Models, Cloud-Based Models 4) By Functionality: Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE), Point Of Care, Product Outcome Evaluation, Medical Research And Clinical Studies 5) By End User: Government Organizations And Third-Party Administrators, Hospitals And Medical Practices, Private Payers, Pharmaceutical, Biotechnology, And Medical Device Companies, Research Centers

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices